Finance committee  For sure. One thing we have mentioned in our brief is that we need direct support in addition to incentivizing charitable giving. I talked a little bit in my speech about that, about the direct subsidies that we need. It terms of incentivizing charitable giving, there are many

Finance committee  Yes. There are about six or seven different ways, and the bottom line is that any form of incentivizing giving is something that we deeply appreciate, in addition to direct subsidies.

Finance committee  I'm sorry, but I'm not quite sure I understand the question. Could you just rephrase it, perhaps?

Finance committee  I think I know what you mean—what percentage of our donations come from individual donors?

Finance committee  Roughly 95% of our revenues come from Canadians who donate say $10 or $20. It's roughly 95%. The other 5% would be either government or corporate donations. Those really are a small part. It's really the individual donor, the individual Canadian, that we rely on in a big way.

Finance committee  In terms of the policy, yes, we support that. I have to be careful, because the CRA says I can't be partisan toward a particular bill, etc. In terms of the policy that's being promoted through that bill, absolutely, we support that. It's important to put the appropriate legal par

Finance committee  Absolutely. Taxation on its own won't do the trick. It's a very important tool, but there are other things that have to be done. To date, the federal government has put health warning labels, or has introduced regulations to put health warning labels and restrict the marketing of

Finance committee  Thank you.

Finance committee  What we do know certainly is that taxes and price impacts behaviour for all types of different behaviours. For example, taxation is actually one of the strongest most powerful tools that we have at our disposal to address tobacco smoking. Early results to date indicate that it's

Finance committee  Thank you very much, Mr. Easter. I'm pleased to be with you today virtually to outline the Heart and Stroke Foundation's priorities for the 2021 federal budget. The first issue I'd like to deal with is pharmacare. Heart and Stroke is seeking concrete steps on the implementatio